Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000902664-23-003641
Filing Date
2023-06-20
Accepted
2023-06-20 16:30:22
Documents
1
Period of Report
2023-06-15

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 6640
  Complete submission text file 0000902664-23-003641.txt   8080
Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Issuer) CIK: 0001651308 (see all company filings)

EIN.: 981209416 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MOURANT OZANNES CORPORATE SERVICES 94 SOLARIS AVENUE CAMANA BAY, GRAND CAYMAN E9 KY1-1108
Business Address
Yi Qingqing (Reporting) CIK: 0001662556 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37686 | Film No.: 231025580